These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35764965)

  • 1. Helminth antigens differentially modulate the activation of CD4
    Adjobimey T; Meyer J; Terkeš V; Parcina M; Hoerauf A
    BMC Med; 2022 Jun; 20(1):241. PubMed ID: 35764965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV-2 immune individuals.
    Altosole T; Rotta G; Uras CRM; Bornheimer SJ; Fenoglio D
    J Immunol Methods; 2023 Apr; 515():113443. PubMed ID: 36842524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.
    Chu Y; Milner J; Lamb M; Maryamchik E; Rigot O; Ayello J; Harrison L; Shaw R; Behbehani GK; Mardis ER; Miller K; Prakruthi Rao Venkata L; Chang H; Lee D; Rosenthal E; Kadauke S; Bunin N; Talano JA; Johnson B; Wang Y; Cairo MS
    J Infect Dis; 2023 Mar; 227(6):788-799. PubMed ID: 36583990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4
    Coulon PG; Prakash S; Dhanushkodi NR; Srivastava R; Zayou L; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Nesburn AB; Kuppermann BD; Bahraoui E; Vahed H; Gil D; Jones TM; Ulmer JB; BenMohamed L
    Front Immunol; 2024; 15():1343716. PubMed ID: 38605956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens.
    Morhart P; Kehl S; Schuh W; Hermes K; Meltendorf S; Neubert A; Schneider M; Brunner-Weinzierl M; Schneider H; Lingel H
    In Vivo; 2023; 37(1):70-78. PubMed ID: 36593041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct SARS-CoV-2 specific NLRP3 and IL-1β responses in T cells of aging patients during acute COVID-19 infection.
    Mahalingam SS; Jayaraman S; Arunkumar A; Dudley HM; Anthony DD; Shive CL; Jacobson JM; Pandiyan P
    Front Immunol; 2023; 14():1231087. PubMed ID: 37799713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.
    Giménez E; Albert E; Torres I; Remigia MJ; Alcaraz MJ; Galindo MJ; Blasco ML; Solano C; Forner MJ; Redón J; Signes-Costa J; Navarro D
    J Med Virol; 2021 Jan; 93(1):375-382. PubMed ID: 32579268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status.
    Gatti A; Zizzo G; De Paschale M; Tamburello A; Castelnovo L; Faggioli PM; Clerici P; Brando B; Mazzone A
    PLoS One; 2023; 18(5):e0285728. PubMed ID: 37220145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Immune Activation and CD4
    Wolday D; Ndungu FM; Gómez-Pérez GP; de Wit TFR
    Front Immunol; 2021; 12():693269. PubMed ID: 34220854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
    Kratzer B; Schlax LC; Gattinger P; Waidhofer-Söllner P; Trapin D; Tauber PA; Sehgal ANA; Körmöczi U; Rottal A; Feichter M; Oberhofer T; Grabmeier-Pfistershammer K; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Mühl B; Kropfmüller A; Negrin B; Kundi M; Valenta R; Pickl WF
    Allergy; 2022 Nov; 77(11):3408-3425. PubMed ID: 35690994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
    Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-reactive IFN-γ-producing CD4
    Olea B; Albert E; Giménez E; Torres I; Amat P; Remigia MJ; Alberola J; Carbonell N; Ferreres J; Blasco ML; Navarro D
    Sci Rep; 2022 Aug; 12(1):14271. PubMed ID: 35995830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helminth infections coincident with active pulmonary tuberculosis inhibit mono- and multifunctional CD4+ and CD8+ T cell responses in a process dependent on IL-10.
    George PJ; Anuradha R; Kumar NP; Sridhar R; Banurekha VV; Nutman TB; Babu S
    PLoS Pathog; 2014 Sep; 10(9):e1004375. PubMed ID: 25211342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ
    Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
    Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4
    Zelba H; Worbs D; Harter J; Pieper N; Kyzirakos-Feger C; Kayser S; Seibold M; Bartsch O; Ködding J; Biskup S
    J Immunol; 2021 Feb; 206(3):580-587. PubMed ID: 33298615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced SARS-CoV-2-Specific CD4
    Pavan Kumar N; Moideen K; Nancy A; Selvaraj N; Renji RM; Munisankar S; Thangaraj JWV; Muthusamy SK; Kumar CPG; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Murhekar MV; Babu S
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.